NCT06241274

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Clinical Study of Moxibustion in the Treatment of Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This study was a prospective, multicenter, single-arm clinical study planned to enroll 60 patients who developed hemorrhagic cystitis after sexually allogeneic hematopoietic stem cell transplantation Patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation were given symptomatic supportive treatment combined with moxibustion covering Shenque, Zhongguo, Guanyuan, and Qihai for 30 minutes every day for 14 days and urine routine was collected every day for 14 days to assess the severity of hemorrhagic cystitis and pain scores to evaluate the effectiveness of moxibustion in treating hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Conditions

• Moxibustion
• Hematopoietic Stem Cell Transplantation
• Hemorrhagic Cystitis
• Treatment

Interventions

Type	Name	Description
OTHER	Moxibustion	Subjects received moxibustion covering Shenque, Zhonggong, Guanyuan, and Qihai for 30 minutes every day for 14 days.
OTHER	Symptomatic supportive treatment	Symptomatic supportive treatment.

Timeline

• Start date: 2024-08-15
• Primary completion: 2025-09-30
• Completion: 2025-12-31
• First posted: 2024-02-05
• Last updated: 2024-07-24

Locations

1 site across 1 country: China